Xeris Pharmaceuticals | XERS - Creditori Commerciali

Prezzo Delle Azioni
5.44
Cambio Giornaliero
-0.14 -2.51%
Mensile
-17.33%
Annuale
-6.37%
Q1 Previsione
5.28




Creditori Commerciali Cambiamento Data
Celltrion KRW 104.19B 15.67B 2025-09
Cspc Pharmaceutical CNY 2.09B 42.45M 2025-06
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Eli Lilly USD 5.38B 1.12B 2025-12
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Ovoca Bio EUR 209K 242K 2024-12
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pharma Mar EUR 54.34M 10.54M 2025-12
Qiagen NV USD 72.66M 2.11M 2025-12
Sartorius EUR 323.2M 61M 2025-09
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 516.14M 31.53M 2025-09